drug development Related News
Ebola vaccine being given to ‘high risk’ Democratic Republic of the Congo
With support of the WHO and partners, the Government of the Democratic Republic of Congo is preparing the Ebola vaccine for high risk populations...
European Commission approves single pill for HIV-1 treatment
The Janssen Pharmaceutical Companies of Johnson & Johnson have today announced that the European Commission has approved JULUCA® (dolutegravir/rilpivirine), a once daily single pill...
EMA recalls multiple sclerosis drug from hospitals and pharmacies
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the multiple sclerosis drug Zinbryta has been recalled from hospitals and...
NICE recommends Biogen’s Avonex for multiple sclerosis
The National Institute for Heath and Care Excellence (NICE) has announced its recommendation of Biogen’s Avonex® (interferon beta-1a), which is used as an option...
New oral drug can protect cancer patients from venous thromboembolism
Taking one tablet a day could be the key to helping treat cancer patients and protect them from venous thromboembolism (VTE), according to research...
Probiotics, breastfeeding could reduce antibiotic resistance in children
Combining probiotics and breastfeeding can help to reduce potential antibiotic resistance in children, according to new research at the 51st ESPHGHAN Annual Meeting.
Infants who...
Osteoporosis drug side effects could be key to treating hair loss
A drug new has been found which could help men and women suffering from hair loss, according to researchers from the University of Manchester’s...
ECDC highlights future threat of drug-resistant gonorrhoea
Following three cases of antibiotic-resistant gonorrhoea in Europe and Australia, there is concern that the growing threat of drug resistance could lead to untreatable...
Survey reveals medical cannabis reduced painkiller use in older adults
A new study has revealed using medical cannabis (or marijuana) substantially reduced chronic pain and dependence on opioid painkillers in 65% of older adults.
Researchers...
Three new medicines recommended for approval
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) have recommended three new medicines for approval that will treat numerous...
Existing antiviral drugs have new uses against multiple viruses
A test of 55 antiviral drugs by the Norwegian University of Science and Technology (NTNU), has found seven compounds that show new effects against...
Orphan medicines availability varies between European countries
A new study from the University of Eastern Finland has showed that there are differences in the availability of orphan medicines between the various...
Irish Pharmaceutical Healthcare Association: accessing new medicines
Oliver O’Connor, of the Irish Pharmaceutical Healthcare Association, reflects on efforts to ensure timely access to new and innovative medicines for all patients in...
Legalising medical cannabis – a German perspective
Germany legalised medical cannabis in March 2017; more than a year on, why are some patients still going without? Georg Wurth shares his thoughts.
Medical...
Medical Cannabis Bike Tour funds glioblastoma clinical trial
Tim Lay and Dr Jonathan Newman explain how a European bike tour is boosting research, challenging assumptions and winning support in the journey towards...
New non-hormonal contraceptive to be developed
Researchers in Sweden have developed a non-hormonal contraceptive for women with no side effects. The contraceptive is one promising use for a new technique...
Single-pill HIV-1 treatment receives positive support
The Janssen Pharmaceutical Companies of Johnson & Johnson have announced that the Committee for Medicinal Products (CHMP) for Human Use of the European Medicines...
Siponimod drug can reduce disability progression of multiple sclerosis
New trial results revealed this week have confirmed that the drug siponimod can reduce the risk of disability progression in those with secondary progressive...
A centre of excellence for medical cannabis research
The Czech Republic-based International Cannabis and Cannabinoids Institute is making an invaluable contribution to medical cannabis research worldwide, as Dr Ethan Russo tells Health...
Does the male contraceptive pill show promise?
Researchers have said that a new male contraceptive pill is showing positive signs when being used daily for a month, with hormone responses consistent...